XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

REVENUE CONCENTRATION | 6 Months Ended
--- | ---
Mar. 31, 2024
Risks and Uncertainties [Abstract] |
REVENUE CONCENTRATION | 10. REVENUE CONCENTRATION For the three months ended March 31, 2024, the Company derived revenue of $21.2 million from three customers, with such customers accounting for 21%, 14% and 11% of the Company’s total revenue, respectively. For the three months ended March 31, 2023, the Company derived revenue of $12.6 million from two customers, with such customers accounting for 16% and 11% of the Company’s total revenue, respectively. For the six months ended March 31, 2024, the Company derived revenue of $24.2 million from two customers, with such customers accounting for 19% and 10% of the Company’s total revenue, respectively. For the six months ended March 31, 2023 the Company derived revenue of $27.5 million from two customers, with each such customer accounting for 15% of the Company’s total revenue, respectively. The corresponding accounts receivable balances of customers from which revenues were in excess of 10% of total revenue were $17.0 million and $9.4 million at March 31, 2024 and 2023, respectively. From a geographic perspective, approximately 71% and 72% of the Company’s total long-term assets as of March 31, 2024 and September 30, 2023, respectively, are associated with the Company’s international subsidiaries. From a geographic perspective, approximately 19% and 23% of the Company’s total long-term assets excluding goodwill and other intangible assets as of March 31, 2024 and September 30, 2023, respectively, are associated with the Company’s international subsidiaries. The United States was the only country that accounted for more than 10% of the Company’s revenue in each of the three months ended March 31, 2024 and March 31, 2023. The United States and the United Kingdom were the only countries that accounted for more than 10% of the Company’s revenue in the six months ended March 31, 2024. The United States was the only country that accounted for more than 10% of the Company’s revenue in the six months ended March 31, 2023. Revenue for the three and six months ended 2024 and 2023 were as follows (amounts in thousands):
|  | Three Months Ended March 31, |  | Six Months Ended March 31,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
United States |  | $ | 37,861 |  | $ | 36,804 |  | $ | 66,291 |  | $ | 75,231
United Kingdom |  | * |  | * |  | 8,536 |  | *
All other countries |  | 9,107 |  | 9,319 |  | 9,058 |  | 16,595
Total revenue |  | $ | 46,968 |  | $ | 46,123 |  | $ | 83,885 |  | $ | 91,826
*Revenues from the United Kingdom were not greater than 10% of the Company’s total revenue for this period.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration